Latin Clinical Trial Center Inc
San Juan 00909
1 studies enrolling now · 4 studies all time
What they study most
Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
Studies at this site
- Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD — Recruiting now
- Pelacarsen Roll-over Extension Program — Recruiting now
- Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
- Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD — Completed